Yu Xia Lin - Net Worth and Insider Trading
Yu Xia Lin Net Worth
The estimated net worth of Yu Xia Lin is at least $4 Million dollars as of 2024-11-07. Yu Xia Lin is the Directors, senior managers of Sansure Biotech Inc and owns about 151,684 shares of Sansure Biotech Inc (SHSE:688289) stock worth over $4 Million. Details can be seen in Yu Xia Lin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yu Xia Lin has not made any transactions after 2024-03-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yu Xia Lin
Yu Xia Lin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yu Xia Lin owns 1 companies in total, including Sansure Biotech Inc (SHSE:688289) .
Click here to see the complete history of Yu Xia Lin’s form 4 insider trades.
Insider Ownership Summary of Yu Xia Lin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:688289 | Sansure Biotech Inc | 2024-03-25 | Directors & senior managers |
Yu Xia Lin Latest Holdings Summary
Yu Xia Lin currently owns a total of 1 stock. Yu Xia Lin owns 151,684 shares of Sansure Biotech Inc (SHSE:688289) as of March 25, 2024, with a value of $4 Million.
Latest Holdings of Yu Xia Lin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:688289 | Sansure Biotech Inc | 2024-03-25 | 151,684 | 24.33 | 3,690,472 |
Holding Weightings of Yu Xia Lin
Yu Xia Lin Form 4 Trading Tracker
According to the SEC Form 4 filings, Yu Xia Lin has made a total of 2 transactions in Sansure Biotech Inc (SHSE:688289) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Sansure Biotech Inc is the sale of 33,821 shares on March 25, 2024, which brought Yu Xia Lin around $492,772.
Insider Trading History of Yu Xia Lin
- 1
Yu Xia Lin Trading Performance
GuruFocus tracks the stock performance after each of Yu Xia Lin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yu Xia Lin is -16.62%. GuruFocus also compares Yu Xia Lin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yu Xia Lin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yu Xia Lin's insider trading performs compared to the benchmark.
Performance of Yu Xia Lin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.5 | | | | | |
| Relative Return to S&P 500(%) | -3.77 | | | | | |
Yu Xia Lin Ownership Network
Ownership Network List of Yu Xia Lin
Ownership Network Relation of Yu Xia Lin
Yu Xia Lin Owned Company Details
What does Sansure Biotech Inc do?
Who are the key executives at Sansure Biotech Inc?
Yu Xia Lin is the Directors & senior managers of Sansure Biotech Inc. Other key executives at Sansure Biotech Inc include senior management xiong xiao yan , senior management wang hai xiao , and Core technical personnel jie ya ping .
Sansure Biotech Inc (SHSE:688289) Insider Trades Summary
Over the past 18 months, Yu Xia Lin made 1 insider transaction in Sansure Biotech Inc (SHSE:688289) with a net sale of 0. Other recent insider transactions involving Sansure Biotech Inc (SHSE:688289) include a net purchase of 162,742 shares made by Dai Li Zhong , a net sale of 1,965 shares made by mou wei min , and a net sale of 0 shares made by ji bo zhi .
In summary, during the past 3 months, insiders sold 0 shares of Sansure Biotech Inc (SHSE:688289) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,965 shares of Sansure Biotech Inc (SHSE:688289) were sold and 162,742 shares were bought by its insiders, resulting in a net purchase of 160,777 shares.
Sansure Biotech Inc (SHSE:688289)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sansure Biotech Inc Insider Transactions
Yu Xia Lin Mailing Address
Above is the net worth, insider trading, and ownership report for Yu Xia Lin. Currently GuruFocus does not have mailing address information for Yu Xia Lin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
